SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001077183-18-000126
Filing Date
2018-12-10
Accepted
2018-12-10 17:14:08
Documents
6
Period of Report
2018-12-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K GENOPTIX CLOSING a8-kgenoptixclosedecember2.htm 8-K 33711
2 EXHIBIT 23.1 CONSENT exhibit232deloitteconsentn.htm EX-23.1 4196
3 EXHIBIT 99.1 GENOPTIX FINANCIALS exhibit991historicalfinanc.htm EX-99.1 1081102
4 EXHIBIT 99.2 UNAUDITED PRO FORMA FINANCIALS exhibit992unauditedproform.htm EX-99.2 443036
5 EXHIBIT 99.3 PRESS RELEASE GENOPTIX exhibit993pressreleasegeno.htm EX-99.3 10293
6 neonewlogopms375chighresa07.jpg GRAPHIC 1059753
  Complete submission text file 0001077183-18-000126.txt   2988252
Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 9419231949
NEOGENOMICS INC (Filer) CIK: 0001077183 (see all company filings)

IRS No.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35756 | Film No.: 181226990
SIC: 8734 Services-Testing Laboratories